PIK3CA and neoplasm: The resulting overactivation of the PI3K pathway promotes tumor growth, resistance to various systemic therapies and poor outcome (Dong et al., 2021[17]; Mosele et al., 2020[35]; Rasti et al., 2022[38]; Sobhani et al., 2018[40]; Yang et al., 2019[44]).